Stoppani, Jim
June 2004
Joe Weider's Muscle & Fitness;Jun2004, Vol. 65 Issue 6, p234
Discusses research being done on anti-AIDS virus as of June 2004. Purpose of inactivated viruses to patients; Observations made by scientists from the National Institute of Allergy and Infectious Diseases on the effect of GB virus C on HIV-infected patients; Assumption on a previously-released study regarding the relationship of GB virus C and hepatitis C virus.


Related Articles

  • Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) in a Northern Alberta Population. Bowker, Samantha L.; Soskolne, Colin L.; Houston, Stan C.; Newman, Stephen C.; Jhangri, Gian S. // Canadian Journal of Public Health;May/Jun2004, Vol. 95 Issue 3, p188 

    Objective: To describe the demographics and estimate the prevalence of hepatitis C virus (HCV) in a cohort of Human Immunodeficiency Virus (HIV) positive patients in Northern Alberta. Methods: A cross-sectional (prevalence) study was performed on a cohort of HIV-positive patients. HCV testing...

  • HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. ANDREONI, M.; GIACOMETTI, A.; MAIDA, I.; MERAVIGLIA, P.; RIPAMONTI, D.; SARMATI, L. // European Review for Medical & Pharmacological Sciences;2012, Vol. 16 Issue 11, p1473 

    Hepatitis C virus (HCV) is the cause of more than three-quarters of liver-related deaths in HIV-seropositive individuals and it is remarkable that today approximately one-quarter of HIV-infected individuals in Europe and the USA have a HCV coinfection. HIV/HCV coinfected patients were more...

  • Does HCV make HIV infection worse? Mascolini, Mark // Research Initiative/Treatment Action!;Summer2014, Vol. 19 Issue 1, p20 

    The article discusses impact of hepatitis C virus (HCV) infection on HIV infection. Topics discussed include impact of HCV infection on mortality of HIV people, on response to combination antiretroviral therapy (cART), and on clinical outcomes and progression to AIDS. Two U.S. studies on HCV/HIV...

  • Quantum Leaps, Microeconomics, and the Treatment of Patients With Hepatitis C and HIV Coinfection. Saag, Michael S. // JAMA: Journal of the American Medical Association;7/23/2014, Vol. 312 Issue 4, p347 

    An introduction is presented in which the editor discusses microeconomics, quantum leap mechanics, and the treatment of patients with hepatitis C virus (HCV) and HIV coinfection, published in the July 23/30, 2014 issue of the "Journal of American Medical Association" (JAMA).

  • Treat Early or Wait and Monitor? A Qualitative Analysis of Provider Hepatitis C Virus Treatment Decision-Making in the Context of HIV Coinfection. Wagner, Glenn; Ryan, Gery; Osilla, Karen Chan; Bhatti, Laveeza; Goetz, Matthew; Witt, Mallory // AIDS Patient Care & STDs;Sep2009, Vol. 23 Issue 9, p715 

    Liver disease is a leading cause of death among patients with HIV coinfected with hepatitis C (HCV); yet, studies show that less than 10% receive HCV treatment, in part because of limited treatment response, high treatment toxicity, and psychosocial barriers to treatment readiness. Using a...

  • Impact of Chronic Hepatitis B Virus (HBV) Infection on Outcomes of Patients Infected with HIV in an Area Where HBV Infection Is Hyperendemic. Sheng, Wang-Huei; Chen, Mao-Yuan; Hsieh, Szu-Min; Hsiao, Chin-Fu; Wang, Jann-Tay; Hung, Chien-Ching; Chang, Shan-Chwen // Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1471 

    Between June 1994 and February 2003, a total of 111 human immunodeficiency virus (HIV)-infected patients with chronic hepatitis B virus (HBV) coinfection and 387 HIV-infected patients without HBV or hepatitis C virus coinfection were prospectively observed to assess the impact of HBV infection...

  • HIV-positive people with HCV have worse response to first antiretroviral combination.  // HIV Treatment ALERTS!;Mar2014, p36 

    The article presents a study on the impact of hepatitis C virus (HCV) in people with HIV infection. The researchers applied accepted statistical methods to identify how HCV impacted response to antiretrovirals examined by four results. The study reveals that people with HCV and HIV gained fewer...

  • Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies. Volberding, Paul A.; Levine, Alexandra M.; Dieterich, Douglas; Mildvan, Donna; Mitsuyasu, Ronald; Saag, Michael // Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1454 

    Anemia in human immunodeficiency virus (HIV)-infected patients can have serious implications, which vary from functional and quality-of-life decrements to an association with disease progression and decreased survival. In 2002, 16 members of the Anemia in HIV Working Group, an expert panel of...

  • Therapeutic Interventions for HIV Infection and Chronic Viral Hepatitis. Cooper, Curtis L. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS69 

    Combination antiretroviral therapy reduces overall and liver-specific morbidity and mortality in coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) and represents the most beneficial pharmaceutical treatment intervention for most coinfected patients. Antiviral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics